Back
Eagle Pharmaceuticals 10K Form
Sell
27
EGRX
Eagle Pharmaceuticals
Last Price:
4.15
Seasonality Move:
7.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-08-09 | 10Q | EGRX/Eagle Pharmaceuticals Quarterly |
| 2023-08-08 | 10Q | EGRX/Eagle Pharmaceuticals Quarterly |
| 2023-05-09 | 10Q | EGRX/Eagle Pharmaceuticals Quarterly |
| 2022-11-09 | 10Q | EGRX/Eagle Pharmaceuticals Quarterly |
| 2022-08-09 | 10Q | EGRX/Eagle Pharmaceuticals Quarterly |
| 2022-05-09 | 10Q | EGRX/Eagle Pharmaceuticals Quarterly |
Receive EGRX News And Ratings
See the #1 stock for the next 7 days that we like better than EGRX
EGRX Financial Statistics
Sales & Book Value
| Annual Sales: | $316.61M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $19.25 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 0.91000 |
|---|---|
| Net Income (TTM): | $11.95M |
| Gross Margin: | $221.67M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Eagle Pharmaceuticals Earnings Forecast
Key Eagle Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 11 years for EGRX is 70.01%.
- The Selling, General & Administrative Expenses for EGRX have been equal to 33.68% of Gross Profit Margin.
- The Research & Development expenses have been 10.77% of Revenue.
- The Interest Expense is 11.35% of Operating Income.
- The Net Earning history of EGRX is 11.26% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 4 years.
Eagle Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | EGRX |
| CUSIP: | 269796 |
| Website: | eagleus.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
EGRX Technical Analysis vs Fundamental Analysis
Sell
27
Eagle Pharmaceuticals (EGRX)
is a Sell
Is Eagle Pharmaceuticals a Buy or a Sell?
-
Eagle Pharmaceuticals stock is rated a Sell
The current Eagle Pharmaceuticals [EGRX] share price is $4.16. The Score for EGRX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.